These findings are supported by data from clinical NSCLC samples and data from TCGA, showing that FXR positively correlates with the expression of IL-6, IL-6ST and p-STAT3 in NSCLC tissues, and this is also more indicative of a poor prognosis. This evidence concerns the gene IL6 and non-small cell lung carcinoma.